Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1996-10-01 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LAMPERTHEIM (67450), Bas-Rhin
PHARMACIE DE LAMPERTHEIM : revenue, balance sheet and financial ratios
PHARMACIE DE LAMPERTHEIM is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LAMPERTHEIM (67450),
this company of category PME
shows in 2022 a revenue of 3.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LAMPERTHEIM (SIREN 409942489)
Indicator
2024
2022
2021
2020
2019
2018
Revenue
N/C
3 379 948 €
3 205 693 €
3 038 424 €
2 946 581 €
2 697 055 €
Net income
190 794 €
188 496 €
237 427 €
177 953 €
231 110 €
231 884 €
EBITDA
N/C
259 653 €
334 792 €
250 347 €
315 433 €
204 445 €
Net margin
N/C
5.6%
7.4%
5.9%
7.8%
8.6%
Revenue and income statement
In 2024, PHARMACIE DE LAMPERTHEIM generates positive net income of 191 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 232 k€ -> 191 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
190 794 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 119%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
118.732%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.949%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LAMPERTHEIM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2024
Debt ratio
48.335
162.753
190.025
150.155
150.292
118.732
Financial autonomy
52.761
30.323
26.783
32.337
30.915
34.949
Repayment capacity
1.646
2.736
3.687
2.907
3.482
None
Cash flow / Revenue
7.302%
7.476%
5.562%
7.041%
5.299%
None%
Sector positioning
Debt ratio
118.732024
2021
2022
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DE LAMPERTHEIM (118.73) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.95%2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DE LAMPERTHEIM (35.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.48 years2022
2021
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good+6 pts over 2 years
In 2022, the repayment capacity of PHARMACIE DE LAMPERTHEIM (3.48) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 169.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
169.344
Liquidity indicators evolution PHARMACIE DE LAMPERTHEIM
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2024
Liquidity ratio
222.287
225.022
172.764
228.232
192.881
169.344
Interest coverage
3.949
4.239
6.202
2.855
4.032
None
Sector positioning
Liquidity ratio
169.342024
2021
2022
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-20 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LAMPERTHEIM (169.34) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
4.03x2022
2021
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good+11 pts over 2 years
In 2022, the interest coverage of PHARMACIE DE LAMPERTHEIM (4.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LAMPERTHEIM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2024
Operating WCR
324 537 €
333 789 €
312 380 €
305 919 €
358 207 €
0 €
Inventory turnover (days)
37
38
39
36
36
0
Customer payment term (days)
7
6
4
6
6
0
Supplier payment term (days)
36
30
31
26
30
0
Positioning of PHARMACIE DE LAMPERTHEIM in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LAMPERTHEIM is estimated at
2 663 625 €
(range 1 854 906€ - 3 984 935€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1854k€2663k€3984k€
2 663 625 €Range: 1 854 906€ - 3 984 935€
NAF 5 année 2024
Valuation method used
Net Income Multiple
190 794 €
×
14.0x
=2 663 625 €
Range: 1 854 907€ - 3 984 936€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LAMPERTHEIM with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LAMPERTHEIM
What is the revenue of PHARMACIE DE LAMPERTHEIM ?
The revenue of PHARMACIE DE LAMPERTHEIM in 2022 is 3.4 M€.
Is PHARMACIE DE LAMPERTHEIM profitable?
Yes, PHARMACIE DE LAMPERTHEIM generated a net profit of 191 k€ in 2024.
Where is the headquarters of PHARMACIE DE LAMPERTHEIM ?
The headquarters of PHARMACIE DE LAMPERTHEIM is located in LAMPERTHEIM (67450), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE DE LAMPERTHEIM ?
The tax return of PHARMACIE DE LAMPERTHEIM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LAMPERTHEIM operate?
PHARMACIE DE LAMPERTHEIM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart